Tuesday, 26 May 2020

Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment

The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing.

from NDTV News - Special https://ift.tt/2M3KuBA
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Challenges To Waqf Law To Be Heard By Supreme Court Today: 10 Points

The Waqf Amendment bill was passed by parliament earlier this month after marathon debates in the Lok Sabha and Rajya Sabha. Now, a three-j...